These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1382984)

  • 1. Effects of selective inhibition of cathepsin B and general inhibition of cysteine proteinases on lysosomal proteolysis in rat liver in vivo and in vitro.
    Ohshita T; Nikawa T; Towatari T; Katunuma N
    Eur J Biochem; 1992 Oct; 209(1):223-31. PubMed ID: 1382984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective role of cathepsins B and D in the lysosomal degradation of endogenous and exogenous proteins.
    Kominami E; Ueno T; Muno D; Katunuma N
    FEBS Lett; 1991 Aug; 287(1-2):189-92. PubMed ID: 1715285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of serum albumin by rat liver and kidney lysosomes.
    Ohshita T; Hiroi Y
    J Nutr Sci Vitaminol (Tokyo); 1998 Oct; 44(5):641-53. PubMed ID: 9919484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin L plays an important role in the lysosomal degradation of L-lactate dehydrogenase.
    Ohshita T; Hiroi Y
    Biosci Biotechnol Biochem; 2006 Sep; 70(9):2254-61. PubMed ID: 16960372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of a cystatin-alpha-sensitive cysteine proteinase in the degradation of native L-lactate dehydrogenase and serum albumin by rat liver or kidney lysosomes.
    Ohshita T; Kido H
    Eur J Biochem; 1994 Nov; 225(3):781-6. PubMed ID: 7957214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of degradation of proteins labeled with fluorescein isothiocyanate by Sephadex G-25 affinity chromatography.
    Ohshita T; Katunuma N
    Anal Biochem; 1992 May; 202(2):400-4. PubMed ID: 1519769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro.
    Murata M; Miyashita S; Yokoo C; Tamai M; Hanada K; Hatayama K; Towatari T; Nikawa T; Katunuma N
    FEBS Lett; 1991 Mar; 280(2):307-10. PubMed ID: 2013328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-mediated introduction of pepstatin-asialofetuin conjugate into lysosomes of rat hepatocytes.
    Furuno K; Miwa N; Kato K
    J Biochem; 1983 Jan; 93(1):249-56. PubMed ID: 6188752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple preparation of rat brain lysosomes and their proteolytic properties.
    Ohshita T; Kido H
    Anal Biochem; 1995 Sep; 230(1):41-7. PubMed ID: 8585628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteases involved in the metabolic degradation of human interleukin-1beta by rat kidney lysosomes.
    Kudo S; Miyamoto G; Kawano K
    J Interferon Cytokine Res; 1999 Apr; 19(4):361-7. PubMed ID: 10334387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of lysosomal degradation of fluorescein isothiocyanate- labelled proteins by Toyopearl HW-40 affinity chromatography.
    Ohshita T; Katanuma N
    J Chromatogr; 1993 Feb; 633(1-2):281-6. PubMed ID: 8450028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of aspartic and cysteine proteinases in albumin degradation by rat kidney cortical lysosomes.
    Baricos WH; Zhou YW; Fuerst RS; Barrett AJ; Shah SV
    Arch Biochem Biophys; 1987 Aug; 256(2):687-91. PubMed ID: 3304168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat liver thiol proteinases: cathepsin B, cathepsin H and cathepsin L.
    Katunuma N; Towatari T; Kominami E; Hashida S; Takio K; Titani K
    Acta Biol Med Ger; 1981; 40(10-11):1419-25. PubMed ID: 6177136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulation of liver cysteine proteinases during macrophagal stimulation and depression].
    Korolenko TA; Svechnikova IG
    Vestn Ross Akad Med Nauk; 1998; (10):26-9. PubMed ID: 9846108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum: inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development.
    Rosenthal PJ; McKerrow JH; Rasnick D; Leech JH
    Mol Biochem Parasitol; 1989 Jun; 35(2):177-83. PubMed ID: 2671722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular design of potent inhibitor specific for cathepsin B based on the tertiary structure prediction.
    Sumiya S; Yoneda T; Kitamura K; Murata M; Yokoo C; Tamai M; Yamamoto A; Inoue M; Ishida T
    Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):299-303. PubMed ID: 1606628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatographic analysis of lysosomal degradation of unlabeled native proteins in vitro by fluorescein isothiocyanate labeling.
    Ohshita T
    Anal Biochem; 1993 Nov; 215(1):17-23. PubMed ID: 8297010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo.
    Towatari T; Nikawa T; Murata M; Yokoo C; Tamai M; Hanada K; Katunuma N
    FEBS Lett; 1991 Mar; 280(2):311-5. PubMed ID: 2013329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of autolysosomes after receptor-mediated introduction of Ep459-asialofetuin conjugate into lysosomes in rat hepatocytes.
    Furuno K; Miwa N; Ishikawa T; Kato K
    Exp Cell Res; 1985 Jan; 156(1):15-21. PubMed ID: 2578110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of rat liver fructose biphosphate aldolase by lysosomal proteinases.
    Katunuma N; Kominami E; Hashida S; Wakamatsu N
    Adv Enzyme Regul; 1982; 20():337-50. PubMed ID: 7051771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.